| Name | Title | Contact Details |
|---|
Clinton Community College (CCC) is a two-year community college located in Clinton, Iowa, founded in 1946. Initially serving veterans returning from World War II, CCC is part of the Eastern Iowa Community Colleges system. The college offers a range of educational programs, including Associate in Arts/College Transfer Classes, Career Technology Programs, and Continuing Education courses aimed at personal and professional development. The main campus is situated at 1000 Lincoln Boulevard, with additional facilities including the CCC Technology Center and the Maquoketa Center, which provide various educational opportunities. CCC also has intercollegiate athletics, featuring mens basketball and womens volleyball teams known as the Cougars. The Paul B. Sharar Foundation supports the college by providing scholarships and funding for students and faculty, enhancing the educational experience at CCC. The college is accredited by the North Central Association of Colleges and Schools, ensuring high educational standards.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Fouts Bros is a fire apparatus manufacturer based in Milledgeville, GA. We are family owned and operated since 1952. We are always looking for talented individuals to join our team! Submit your resumé at foutsfire.com.